Co-delivery of hydrophilic and hydrophobic anticancer drugs using biocompatible pH-sensitive lipid-based nano-carriers for multidrug-resistant cancers
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Co-delivery of hydrophilic and hydrophobic anticancer drugs using biocompatible pH-sensitive lipid-based nano-carriers for multidrug-resistant cancers
Authors
Keywords
-
Journal
RSC Advances
Volume 7, Issue 48, Pages 30008-30019
Publisher
Royal Society of Chemistry (RSC)
Online
2017-06-09
DOI
10.1039/c7ra01736g
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metal complexes of curcumin and curcumin derivatives for molecular imaging and anticancer therapy
- (2016) Michael Pröhl et al. COORDINATION CHEMISTRY REVIEWS
- Co-delivery of doxorubicin and the traditional Chinese medicine quercetin using biotin–PEG2000–DSPE modified liposomes for the treatment of multidrug resistant breast cancer
- (2016) Jiulong Zhang et al. RSC Advances
- Dietary polyphenols, oxidative stress and antioxidant and anti-inflammatory effects
- (2016) Hua Zhang et al. Current Opinion in Food Science
- Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer
- (2016) Yumin Zhang et al. Scientific Reports
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice
- (2015) Xiaojing Zhao et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Self-degrading niosomes for encapsulation of hydrophilic and hydrophobic drugs: An efficient carrier for cancer multi-drug delivery
- (2015) Varsha Sharma et al. Materials Science & Engineering C-Materials for Biological Applications
- Co-delivery of doxorubicin hydrochloride and verapamil hydrochloride by pH-sensitive polymersomes for the reversal of multidrug resistance
- (2015) Nuannuan Li et al. RSC Advances
- PEG–PLGA–PLL nanoparticles in combination with gambogic acid for reversing multidrug resistance of K562/A02 cells to daunorubicin
- (2015) Peipei Xu et al. RSC Advances
- Development of nordihydroguaiaretic acid derivatives as potential multidrug-resistant selective agents for cancer treatment
- (2015) Lin-Chiang Sherlock Huang et al. RSC Advances
- Curcumin-Encapsulated Polymeric Micelles Suppress the Development of Colon Cancer In Vitro and In Vivo
- (2015) Xi Yang et al. Scientific Reports
- A review on phospholipids and their main applications in drug delivery systems
- (2015) Jing Li et al. Asian Journal of Pharmaceutical Sciences
- Recent developments in the co-delivery of siRNA and small molecule anticancer drugs for cancer treatment
- (2014) Manju Saraswathy et al. Materials Today
- Nanopreparations to overcome multidrug resistance in cancer
- (2013) Niravkumar R. Patel et al. ADVANCED DRUG DELIVERY REVIEWS
- Simultaneous delivery of doxorubicin and curcumin encapsulated in liposomes of pegylated RGDK-lipopeptide to tumor vasculature
- (2013) Sugata Barui et al. BIOMATERIALS
- Efficacy and Safety of Curcumin in Major Depressive Disorder: A Randomized Controlled Trial
- (2013) Jayesh Sanmukhani et al. PHYTOTHERAPY RESEARCH
- Evaluating the antioxidant capacity of natural products: A review on chemical and cellular-based assays
- (2012) Camilo López-Alarcón et al. ANALYTICA CHIMICA ACTA
- Epirubicin: Is it like doxorubicin in breast cancer? A clinical review
- (2012) Mustafa Khasraw et al. BREAST
- Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles
- (2012) Jinghua Duan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Impact of Curcumin Supersaturation in Antibacterial Photodynamic Therapy—Effect of Cyclodextrin Type and Amount: Studies on Curcumin and Curcuminoides XLV
- (2012) Anne Bee Hegge et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance
- (2012) Mar Creixell et al. Nano Today
- Columbamine suppresses the proliferation and neovascularization of metastatic osteosarcoma U2OS cells with low cytotoxicity
- (2012) Meimei Bao et al. TOXICOLOGY LETTERS
- Optimised nano-formulation on the bioavailability of hydrophobic polyphenol, curcumin, in freely-moving rats
- (2011) Yin-Meng Tsai et al. FOOD CHEMISTRY
- Mechanisms and management of doxorubicin cardiotoxicity
- (2011) Y. Shi et al. HERZ
- Coformulation of Doxorubicin and Curcumin in Poly(d,l-lactide-co-glycolide) Nanoparticles Suppresses the Development of Multidrug Resistance in K562 Cells
- (2011) Ranjita Misra et al. MOLECULAR PHARMACEUTICS
- The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator
- (2009) Ji-Young Kim et al. BIOMATERIALS
- Osteosarcoma treatment: state of the art
- (2009) Hang T. Ta et al. CANCER AND METASTASIS REVIEWS
- Treatment of older adults with acute myeloid leukemia: state of the art and current perspectives
- (2008) M. A. Sekeres HAEMATOLOGICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now